This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bartocci, A. Articles by Chirigos, M. A. Search for Related Content PubMed PubMed Citation Articles by Bartocci, A. Articles by Chirigos, M. A.

Enhancing Activity of Various Immunoaugmenting Agents on the Delayed-Type Hypersensitivity Response in Mice

Laboratory of Chemical Pharmacology, National Cancer Institute, NIH, Bethesda, Maryland 20205

Six immunoaugmenting agents were tested in the delayed-type hypersensitivity reaction (DTH) in normal BALB/c x DBA/2 mice. The agents tested, levan, lentinan, mannozym, maleic anhydride divinyl ether, polyriboinosinic-polycytidylic acidpoly-L-lysine, and highly purified L-cell interferon, gave significant increases in the DTH response above the sheep red blood cell control. The schedule of doses for each agent corresponded with previous experiments from this laboratory of the maximum natural killer cell activity, macrophage activation, and interferon induction. Highly purified L-cell interferon was capable of eliciting a significant DTH response when given 4 hr after the initial challenge with sheep erythrocytes. In addition, -carrageenan, a macrophage-cytotoxic agent which can render the macrophage inactive, was found to suppress the DTH response to levels slightly above phosphate-buffered saline controls. The carrageenan-induced suppression of the DTH response could be abrogated by coadministration with immunoaugmenting agents to levels attained with the immunoaugmenting agents alone.

¹ Present address: Litton Bionetics, Inc., Kensington, Md. 20795.

² Supported by Deutsche Krebshilfe e.V., 5300 Bonn, Federal Republic of Germany.

³ To whom requests for reprints should be addressed.

Received 8/17/81. Accepted 5/28/82.